Arul P. Nancy
Chennai, TN 600031, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Plasma Matrix Metalloproteinases Signature as Biomarkers for Pediatric Tuberculosis Diagnosis: A Prospective Case-Control Study.
Journal: Diseases (Basel, Switzerland)
Published: March 25, 2025
Acute-phase proteins as biomarkers of inflammation in HIV patients with latent tuberculosis: a prospective study.
Journal: Frontiers in immunology
Published: December 26, 2024
Impact of Strongyloides stercoralis Coinfection on Disease Severity and Treatment Outcomes in Pulmonary Tuberculosis.
Journal: Open forum infectious diseases
Published: September 04, 2024
Elucidating the Immune Response to SARS-CoV-2: Natural Infection versus Covaxin/Covishield Vaccination in a South Indian Population.
Journal: Viruses
Published: June 04, 2024
Inflammatory cytokine responses in pediatric tuberculosis with or without SARS-CoV-2 seropositivity.
Inflammatory cytokine responses in pediatric tuberculosis with or without SARS-CoV-2 seropositivity.
Journal: The Journal of infection
Published: May 30, 2024
Effect of Metformin on systemic chemokine responses during anti-tuberculosis chemotherapy.
Journal: Tuberculosis (Edinburgh, Scotland)
Published: December 19, 2023
Immune Profiles in Multisystem Inflammatory Syndrome in Children with Cardiovascular Abnormalities.
Journal: Viruses
Published: August 10, 2023
Multisystem inflammatory syndrome in children characterized by enhanced antigen-specific T-cell expression of cytokines and its reversal following recovery.
Journal: Frontiers in pediatrics
Published: June 06, 2023
BCG vaccination is associated with longitudinal changes in systemic eicosanoid levels in elderly individuals: A secondary outcome analysis.
Journal: Heliyon
Published: March 30, 2023
BCG vaccination induces enhanced humoral responses in elderly individuals.
Journal: Tuberculosis (Edinburgh, Scotland)
Published: November 16, 2022
Chitinase and indoleamine 2, 3-dioxygenase are prognostic biomarkers for unfavorable treatment outcomes in pulmonary tuberculosis.
Journal: Frontiers in immunology
Published: November 09, 2022
Last Updated: 09/26/2026